Twist Bioscience Begins Shipping of Synthetic RNA Controls for Kappa (B.1.617.1) SARS-CoV-2 Variants for Development of Accurate Tests
Retrieved on:
Tuesday, June 8, 2021
Health, Infectious diseases, Technology, Nanotechnology, Research, Science, Biotechnology, Coronaviridae, Sarbecovirus, Zoonoses, Variants of SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2, Lineage B.1.617, Severe acute respiratory syndrome coronavirus, Lineage B.1.526, Kappa variant of COVID-19
The company is also working on controls for the SARS-CoV-2 Delta (B.1.617.2) and B.1.617.3 variants.
Key Points:
- The company is also working on controls for the SARS-CoV-2 Delta (B.1.617.2) and B.1.617.3 variants.
- Unfortunately, India is experiencing a massive outbreak and overwhelming challenge with new viral variants and a largely unvaccinated population.
- The Twist synthetic controls are designed based on specific SARS-CoV-2 variants, cover the full viral genome and are sequence-verified.
- For customers interested in alternative variants of SARS-CoV-2, or synthetic RNA or DNA controls for other sequences, Twist can provide custom controls in multiple formats.